These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21645228)

  • 1. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay.
    Gris JC; Faillie JL; Cochery-Nouvellon E; Lissalde-Lavigne G; Lefrant JY
    J Thromb Haemost; 2011 Jun; 9(6):1252-5. PubMed ID: 21645228
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Disseminated Intravascular Coagulation in Critically Ill Pediatric Hemato-oncology Patients with Septic Shock.
    Jhang WK; Park SJ
    Thromb Haemost; 2020 Nov; 120(11):1505-1511. PubMed ID: 32772349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
    Dempfle CE; Wurst M; Smolinski M; Lorenz S; Osika A; Olenik D; Fiedler F; Borggrefe M
    Thromb Haemost; 2004 Apr; 91(4):812-8. PubMed ID: 15045145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C; Wuillemin WA; Zeerleder S
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
    Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of automated fibrin generation markers in patients with septic shock: a SepsiCoag ancillary study.
    Gris JC; Cochery-Nouvellon E; Bouvier S; Jaber S; Albanese J; Constantin JM; Orban JC; Morel J; Leone M; Deras P; Elotmani L; Lavigne-Lissalde G; Lefrant JY
    Br J Haematol; 2018 Nov; 183(4):636-647. PubMed ID: 30203833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited utility of a rapid quantitative enzyme-linked fluorescent assay for the D-dimer in the diagnosis of overt disseminated intravascular coagulation.
    Sharma P; Saxena R
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):609-13. PubMed ID: 20211928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shock in patients with disseminated intravascular coagulation (DIC).
    Matsuda T; Shimada K
    Jpn Circ J; 1977 Apr; 41(4):376-82. PubMed ID: 875222
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation.
    Zheng X; Chen S; Zhang F; Ye M; Chen J; Zhang S
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):248-252. PubMed ID: 33955858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH.
    Suzuki K; Wada H; Imai H; Iba T; Thachil J; Toh CH;
    J Thromb Haemost; 2018 Jul; 16(7):1442-1444. PubMed ID: 29846034
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the innovance d-dimer assay for the diagnosis of disseminated intravascular coagulopathy in different clinical settings.
    Khalafallah A; Jarvis C; Morse M; Albarzan AM; Stewart P; Bates G; Hayes R; Robertson I; Seaton D; Brain T
    Clin Appl Thromb Hemost; 2014 Jan; 20(1):91-7. PubMed ID: 22859588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Diagnostic Performance of Fibrin Monomer in Comparison to d-Dimer in Patients With Overt and Nonovert Disseminated Intravascular Coagulation.
    Singh N; Pati HP; Tyagi S; Upadhyay AD; Saxena R
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):460-465. PubMed ID: 26574574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
    Raschka C; Róka L
    Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which Septic Shock Patients With Non-Overt DIC Progress to DIC After Admission? Point-of-Care Thromboelastography Testing.
    Kim SM; Kim SI; Yu G; Kim YJ; Kim WY
    Shock; 2022 Feb; 57(2):168-174. PubMed ID: 35025842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical implications of analyses of fibrinogen and fibrin-derivatives in DIC].
    Magari Y; Ito M; Itoga T
    Rinsho Ketsueki; 1986 Oct; 27(10):1992-2007. PubMed ID: 3820619
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disseminated intravascular coagulation: role of the International Society on Thrombosis and Haemostasis (ISTH) diagnostic scoring system].
    Bouzidi S; Daiki M; Nasr AA; Nsiri K; Layouni S; Hajjej Z; Fekih-Mrissa N; Ferjani M; Nsiri B
    Pan Afr Med J; 2020; 36():154. PubMed ID: 32874418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
    Andersen MG; Hvas CL; Tønnesen E; Hvas AM
    Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated fibrin-related markers in patients with malignant diseases suspected of having thrombotic disorders.
    Nomura H; Wada H; Mizuno T; Yamashita Y; Saito K; Kitano S; Katayama N; Yamada N; Sugiyama T; Sudo A; Usui M; Isaji S; Nobori T
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):266-72. PubMed ID: 19648145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Dimer Testing: Laboratory Aspects and Current Issues.
    Thachil J; Lippi G; Favaloro EJ
    Methods Mol Biol; 2017; 1646():91-104. PubMed ID: 28804821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.